A regulatory role of fibroblast growth factor in the expression of decorin, biglycan, betaglycan and syndecan in osteoblasts from patients with Crouzon's syndrome

European Journal of Cell Biology

Volumn 78, Issue 5, 1999, Pages 323-330

  Bodo, Maria ^a   Baroni, Tiziano ^b   Carinci, Francesco ^a   Becchetti, Ennio ^b   Bellucci, Catia ^b   Conte, Carmela ^b   Pezzetti, Furio ^a   Evangelisti, Rita ^a   Tognon, Mauro ^a   Carinci, Paolo ^c  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

bFGF; Crouzon osteoblasts; Interleukins; Procollagen 1(I); Proteoglycan core protein

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BETAGLYCAN; BIGLYCAN; COLLAGEN; COMPLEMENTARY DNA; CYTOKINE; DECORIN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBRONECTIN; GLYCOSAMINOGLYCAN; MESSENGER RNA; PROCOLLAGEN; PROTEOHEPARAN SULFATE; SYNDECAN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BONE DEVELOPMENT; CASE REPORT; CONTROLLED STUDY; CROUZON SYNDROME; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MORPHOGENESIS; MUTATION; NORTHERN BLOTTING; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKULL;

EID: 0033036790     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-9335(99)80066-1     Document Type: Article

References (53)

1. Andres, J. L., D. DeFalcis, M. Noda, J. Massagué: Binding of two growth factor families to separate domains of the proteoglycan betaglycan. J. Biol. Chem. 267, 5927-5930 (1992).
2. Bodo, M., G. Venti, T. Baroni, C. Bellucci, M. Giammarioli, E. Donti, G. Paludetti, G. Stabellini, P. Carinci: Phenotype of in vitro human otosclerotic cells and its modulation by TGFβ. Cell. Mol. Biol. 41, 1039-1049 (1995).
3. Bodo, M., F. Carinci, T. Baroni, E. Becchetti, M. Giammarioli, C. Bellucci, F. Pezzetti, R. Evangelisti, P. Carinci: Effect of interleukins on Crouzon fibroblast phenotype in vitro. Release of cytokines and IL-6 mRNA expression. Cytokine 8, 772-783 (1996).
4. Bodo, M., F. Carinci, T. Baroni, M. Giammarioli, C. Bellucci, F. Pezzetti, E. Becchetti, R. Evangelisti, P. Carinci: Apert's syndrome: differential in vitro production of matrix macromolecules and its regulation by interleukins. Eur. J. Clin. Invest. 27, 36-42 (1997).
5. Bodo, M., P. Carinci, G. Venti, M. Giammarioli, E. Donti, G. Stabellini, G. Paludetti, E. Becchetti: Glycosaminoglycan metabolism and cytokine release in normal and otosclerotic human bone cells interleukin-1 treated. Connective Tissue Res. 36, 231-240 (1997).
6. Bodo, M., F. Carinci, T. Baroni, E. Becchetti, C. Bellucci, M. Giammarioli, F. Pezzetti, M. Tognon, P. Carinci: Interleukin pattern of Apert fibroblasts in vitro. Eur. J Cell Biol. 75, 383-388 (1998).
7. Bresnich, S., S. Schendel: Apert's syndrome correlates with low fibroblast growth factor receptor activity in stenosed cranial sutures. J. Craniof. Surg. 9, 92-95 (1998).
8. Carinci, F., A. Avantaggiato, C. Curioni: Crouzon syndrome: cephalometric analysis and evaluation of pathogenesis. Cleft Palate-Craniofacial. J. 31, 201-209 (1994).
9. Chi, J. E., C. A. Hatfield, R. F. Krzesicki, W. F. Herblin: Interactions between interleukin-1 and basic fibroblast growth factor on articular chondrocytes. Arthritis Rheum. 34, 314-332 (1991).
10. Chomczynski, P., N. Sacchi: Single step method of RNA isolation by acid guanidine thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159 (1987).
11. Cohen, M. M.: Craniosynostosis. Raven Press. New York 1986.
12. Cohen, M. M., S. Kreiborg Jr.: Skeletal abnormalities in the Apert syndrome. Am. J. Med. Genet. 47, 624-632 (1993).
13. Conrad, G. W., C. Hamilton, C. Haynes: Differences in glycosaminoglycans synthesized by fibroblast-like cells from cornea, heart and skin. J. Biol. Chem. 252, 6861-6870 (1977).
14. Cross, D.: Growth factors in development, transformation, and tumorigenesis. Cell 64, 271-280 (1991).
15. Fedarko, N. S., J. D. Termine, M. F. Young, P. G. Robey: Temporal regulation of hyaluronan and proteoglycan metabolism by human bone cells in vitro. J. Biol. Chem. 265, 12200-12209 (1990).
16. Fisher, L. W.: The human genes for biglycan and decorin. In: J. E. Scott (Ed.): Dermatan sulphate proteoglycans pp. 103-117. Portland Press. London and Chapel Hill 1993
17. Frenkel, S. R., M. S. Herskovits, I. J. Singh: Fibroblast growth factor: effects on osteogenesis and chondrogenesis in the chick embryo. Acta Anat. 145, 265-268 (1992).
18. Frenz, D. A., W. Liu, J. D. Williams, V. Hatcher, V. Galinovic-Schwartz, K. C. Flanders, R. R. Van De Water: Induction of chondrogenesis: requirement for synergistic interaction of basic fibroblast growth factor and transforming growth factor-beta. Development 120, 415-424 (1994).
19. Fukuo, K., T. Inoue, S. Morimoto, T. Nakahashi, O. Yasuda, S. Kitano, R. Sasada, T. Ogihar: Nitric oxide mediates cytotoxicity and basic fibroblast growth factor release in cultured vascular smooth muscle cells. J. Clin. Invest. 95, 669-676 (1995).
20. Galvin, B. D., K. C. Hart, A. N. Meyer, M. K. Webster: Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR2) and FGFR2/Neu chimeras. Proc. Natl. Acad. Sci. USA 93, 7894-7899 (1996).
21. Gannou-Zaki, L., I. Pieri, J. Badet, D. Barritault: Interaction of basic fibroblast growth (FGFR2) with non responsive HeLa cells. Exp. Cell Res. 213, 375-382 (1994).
22. Gillies, R. J., N. Dieder, M. Denton: Determination of cell number in monolayer cultures. Anal. Biochem. 159, 109-116 (1986).
23. Globus, R. K., P. Patterson-Buckendahl, D. Gospodarowicz: Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth factor β. Endocrinology 123, 98-105 (1988).
24. Gospodarowicz, D.: Growth factors and their action in vivo and in vitro. J. Pathol. 141, 201-219 (1983).
25. Ichiki, Y., E. A. Smith, C. E. Leroy, M. Trojanowska: Basic fibroblast growth factor inhibits basal and transforming growth factor-β induced collagen α2(I) gene expression in scleroderma and normal fibroblasts. J. Rheumatol. 24, 90-95 (1997).
26. Johnson, D. E., L. T. Williams: Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60, 1-41 (1993).
27. Kan, M., F. Wang, T. B. Kan Makiko, J. L. Gabriel, W. L. McKeehan: Divalent cation and heparin/heparan sulfate cooperate to control assembly and activity of the fibroblast growth factor receptor complex. J. Biol. Chem. 271, 26143-26148 (1996).
28. Kilkenny, D. M., D. J. Hill: Perinuclear localization of an intracellular binding protein related to the fibroblast growth factor (FGF) receptor 1 is temporally associated with the nuclear trafficking of FGF-2 in proliferating epiphyseal growth plate chondrocytes. Endocrinology 137, 5078-5089 (1996).
29. LaBarca, C., K. Paigen: A simple, rapid, and sensitive DNA assay procedure. Anal. Biochem. 102, 344-352 (1980).
30. 3 on alkaline phosphatase in osteoblastic osteosarcoma cells. J. Biol. Chem. 257, 3362-3365 (1982).
31. Maniatis, T., E. F. Fritsch, J. Sambrook: Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory. Cold Spring Harbor, New York 1982.
32. Moscatelli, D.: High and low affinity binding sites for basic fibroblast growth factor on culured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J. Cell. Physiol. 131, 123-130 (1987).
33. Muenke, M., U. Schell, A. Hehr, N. H. Robin, H. W. Losken, A. Schinzel, L. J. Pulleyn, P. Rutland, W. Reardon, S. Malcom, R. M. Winter: A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nature Genet. 8, 269-274 (1994).
34. Park, W. J., C. Theda, N. E. Maestri, G. A. Meyers, J. S. Fryburg, C. Dufresne, M. M. Cohen Jr., E. W. Jabs: Analysis of phenotypic features and FGFR2 mutations in Apert syndrome. Am. J. Hum. Genet. 57, 321-328 (1995).
35. Pasquale, E. B., S. J. Singer: Identification of a developmentally regulated protein-tyrosine kinase by using anti-phosphotyrosine antibodies to screen a cDNA expression library. Proc. Natl. Acad. Sci. USA 86, 5449-5453 (1989).
36. Pitchard, J. J., H. Scott, F. G. Girgis: The structure and development of cranial and facial sutures. J. Anat. 30, 73-87 (1956).
37. Pulkkinen, L., K. Kainulainen, T. Krusius, P. Mäkinen, J. Schollin, K. H. Gustavsson, L. Peltonen: Deficient expression of the gene coding for decorin in a lethal form of Marfan syndrome. J. Biol. Chem. 265, 17780-17785 (1990).
38. Ramirez, F., M. Di Liberto: Complex and diversified regulatory programs control the expression of vertebrate genes. FASEB J. 4, 1616-1623 (1990).
39. Reardon, W., R. M. Winter, L. J. Pulleyn, B. M. Jones, S. Malcom: Mutations in the fibroblast growth factor 2 gene cause Crouzon syndrome. Native Genet. 8, 98-103 (1994).
40. Rivera, S., S. J. Gold, C. M. Gall: Interleukin-1β increases basic fibroblast growth factor mRNA expression in adult rat brain and organotypic hippocampal cultures. Mol. Brain Res. 27, 12-26 (1994).
41. Roghani, M., A. Mansukhani, P. Dell'Era, P. Bellosta, C. Basilico, D. B. Rifkin, D. Moscatelli: Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. J. Biol. Chem. 269, 3976-3984 (1994).
42. Roodman, G. D., N. Kurihara, Y. Ohsaki: Interleukin-6: A potential autocrine/paracrine factor in Paget's disease of bone. J. Clin. Invest. 89, 46-52 (1992).
43. Ruoslahti, E.: Proteoglycans in cell regulation. J. Biol. Chem. 264, 13369-13372 (1989).
44. Rutland, P., L. J. Pulleien, W. Reardon, M. Baraister, R. Hayward, B. Jones, S. Malcolm, R. M. Winter, M. Oldridge, S. F. Slaney: Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nature Genet. 9, 173-176 (1995).
45. Schönherr, E., P. Witsch-Prehm, B. Harrach, H. Robenek, J. Rauterberg, H. Kresse: Interaction of biglycan with type I collagen. J. Biol. Chem. 270, 2776-2783 (1995).
46. Shiang, R., L. M. Thompson, Y. Z. Zhu, D. M. Church, T. J. Fielder, M. Bocian, S. T. Winokur, J. J. Wasmuth: Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78, 335-342 (1994).
47. Tessler, S., G. Neufeld: Basic fibroblast growth factor accumulates in the nuclei of various bFGF producing cell types. J. Cell. Physiol. 145, 310-311 (1990).
48. Wilkie, A. O. M., G. M. Morris-Kay, E. J. Jones, J. K. Heath: Functions of fibroblast growth factors and their receptors. Curr. Biol. 5, 500-507 (1995).
49. Wilkie, A. O. M., S. F. Slaney, M. Oldridge, M. D. Poole, G. J. Asworth, A. D. Hockley, R. D. Hayward, D. J. David, L. J. Pulleyn, M. D. Rutland, S. Malcom, R. M. Winter, W. Reardon: Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nature Genet. 9, 165-175 (1995).
50. Wilkie, A. O. M., S. A. Wall: Craniosynostosis: novel insights into pathogenesis and treatment. Curr. Opin. Neurol. 9, 146-152 (1996).
51. Wilkie, A. O. M.: Craniosynostosis: genes and mechanism. Hum. Mol. Genet. 6, 1647-1656 (1997).
52. Wong, M. M., L. G. Rao, H. Ly, L. Hamilton, S. Ish-Shalom, W. Sturtridge, J. Tong, R. McBroom, R. G. Josse, T. M. Murray: In vitro study of osteoblastic cells from patients with idiopathic osteoporosis and comparison with cells from non-osteoporotic controls. Osteoporosis Int. 4, 21-31 (1994).
53. Yayon, A., M. Klagsbrun, J. D. Esko, P. Leder, D. M. Ornitz: Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841-848 (1991).